Stock Markets March 26, 2026

Citron Research Shorts Fundrise Growth Tech Fund, Highlights Wide Premium and Marketing Questions

Research firm points to a stark gap between market price and asset value, and presses regulators on influencer payments and marketing disclosures

By Caleb Monroe VCX DXYZ
Citron Research Shorts Fundrise Growth Tech Fund, Highlights Wide Premium and Marketing Questions
VCX DXYZ

Citron Research said it has opened a short position in the Fundrise Growth Tech Fund (VCX), arguing the fund is trading at a materially higher level than its disclosed net asset value and raising questions about the fund sponsor's marketing practices and prior regulatory findings. The firm highlighted a large discrepancy between VCX's market price and its underlying asset valuation, noted previously disclosed marketing expenses, and urged the SEC to determine whether current solicitation activities are properly disclosed.

Key Points

  • Citron Research initiated a short on the Fundrise Growth Tech Fund (VCX), citing a large gap between its market price (above $400) and underlying asset value ($19).
  • The firm highlighted the sponsor's prior SEC charge in August 2023 for paying over 200 influencers and publishers $8 million without proper disclosure, and raised questions about current marketing spend and solicitation practices.
  • Citron compared VCX to Destiny Tech100 (DXYZ), noting DXYZ's launch pricing and subsequent trading levels, and calculated an implied VCX price near $26 if its premium compressed to DXYZ's current premium of approximately 35%.

Citron Research announced it has established a short position in the Fundrise Growth Tech Fund (VCX), citing what it describes as a substantial divergence between the fund's trading price and the value of its underlying assets.

According to Citron, VCX is trading above $400 per share while the fund's assets are valued at $19 per share. The research firm argued that this disparity poses a valuation concern for investors holding positions in the fund.

In its public statement, Citron also revisited regulatory issues involving the fund's sponsor, Fundrise Advisors LLC. The Securities and Exchange Commission charged Fundrise Advisors in August 2023 for violations related to paid solicitation. The SEC's action, as cited by Citron, found that Fundrise paid more than 200 social media influencers and online publishers a total of $8 million without appropriate disclosure.

Citron drew attention to disclosures in VCX's prospectus, which lists "Other Expenses - Marketing: 0.42%" as a fee charged to investors. The research firm translated that percentage into an approximate dollar amount, stating it equates to roughly $3 million in annual marketing expenses.

Beyond the headline numbers, Citron questioned the registration of the domain GetVCX.com, suggesting the domain itself may function as a marketing pitch for the fund. The research firm asked regulators to examine whether Fundrise is currently compensating influencers or content publishers to promote VCX, whether the GetVCX.com domain constitutes a misleading solicitation, and how the disclosed marketing expense is being spent.


Citron placed VCX in context by comparing it to Destiny Tech100 (DXYZ), another closed-end vehicle that provides retail access to private technology companies. Citron noted that when DXYZ launched in March 2024 it traded above $75 per share while its net asset value was about $5 per share. The research firm said DXYZ later traded at roughly $27 with a NAV of nearly $20 per share.

Using DXYZ's current premium, which Citron estimated at approximately 35%, the firm calculated an implied VCX price of about $26 if VCX's premium were to compress to the same level. On that basis, Citron estimated a potential decline of over 93% from VCX's then-current trading levels.

The announcement also noted a shareholder lock-up affecting approximately 100,000 investors who are unable to sell their positions until September. Citron asked the SEC Division of Enforcement to investigate whether current promotional activities are appropriately disclosed and to evaluate the marketing expenditures tied to VCX.

The statements from Citron outline valuation and disclosure questions and request regulatory scrutiny, while citing prior SEC findings related to the fund sponsor.

Risks

  • A significant valuation mismatch between market price and net asset value for VCX could produce large losses for shareholders - impacting retail investors and the closed-end fund sector.
  • Potential undisclosed or ongoing payments to influencers or publishers for fund promotion could prompt regulatory enforcement or reputational damage for the sponsor - affecting marketing and asset management practices.
  • Investor lock-up provisions leave roughly 100,000 shareholders unable to sell until September, creating liquidity constraints and concentration risk for retail holders of the fund.

More from Stock Markets

NASA’s Artemis Overhaul Shifts Advantage to Firefly as Gateway Program Is Paused Mar 26, 2026 Chip Makers Among Heaviest Losses as Market Sees Wide Swings Thursday Mar 26, 2026 South Korean Auto Supplier Surges 51% in March, Leading Global Gains Mar 26, 2026 Blackstone Commits $250 Million to UAE Payments and Data Platform Amid Regional Conflict Mar 26, 2026 GlobalFoundries Initiates Patent Litigation Against Tower Semiconductor Mar 26, 2026